TScan Therapeutics
TCRX
#7497
Rank
$0.28 B
Marketcap
$5.29
Share price
4.13%
Change (1 day)
16.78%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$2.89

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.89. In 2022 the company made an earnings per share (EPS) of -$2.75 a decrease over its 2021 EPS that were of -$2.18.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.895.09%
2022-$2.7526.25%
2021-$2.1899.58%
2020-$1.09